The problem is that this preference, while valid from a quality-of-life perspective, trades efficacy for comfort without data showing that the trade is worthwhile long-term
Practical Considerations for Therapy Selection Choosing between oral and injectable GLP-1 therapy involves more than just efficacy and adherence
identified FSP1, formerly known as apoptosis-inducing factor mitochondrial 2 (AIFM2), through an expression cloning approach, revealing its ability to prevent ferroptosis caused by GPX4 deletion
Because you are introducing the new dose while the previous dose is still at a slightly higher level in your blood than usual, your body may react
A consultation with our medical team is required to determine if this therapy is appropriate for you
Some patients report that the oral formulation causes less reflux than injectable semaglutide, while others find the required empty-stomach dosing triggers more morning nausea and reflux